首页> 美国卫生研究院文献>International Journal of Molecular Sciences >Treatment of Stress Urinary Incontinence with Muscle Stem Cells and Stem Cell Components: Chances Challenges and Future Prospects
【2h】

Treatment of Stress Urinary Incontinence with Muscle Stem Cells and Stem Cell Components: Chances Challenges and Future Prospects

机译:用肌肉干细胞和干细胞组分治疗应激尿失禁:机会挑战和未来前景

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Urinary incontinence (UI) is a major problem in health care and more than 400 million people worldwide suffer from involuntary loss of urine. With an increase in the aging population, UI is likely to become even more prominent over the next decades and the economic burden is substantial. Among the different subtypes of UI, stress urinary incontinence (SUI) is the most prevalent and focus of this review. The main underlying causes for SUI are pregnancy and childbirth, accidents with direct trauma to the pelvis or medical treatments that affect the pelvic floor, such as surgery or irradiation. Conservative approaches for the treatment of SUI are pelvic physiotherapy, behavioral and lifestyle changes, and the use of pessaries. Current surgical treatment options include slings, colposuspensions, bulking agents and artificial urinary sphincters. These treatments have limitations with effectiveness and bear the risk of long-term side effects. Furthermore, surgical options do not treat the underlying pathophysiological causes of SUI. Thus, there is an urgent need for alternative treatments, which are effective, minimally invasive and have only a limited risk for adverse effects. Regenerative medicine is an emerging field, focusing on the repair, replacement or regeneration of human tissues and organs using precursor cells and their components. This article critically reviews recent advances in the therapeutic strategies for the management of SUI and outlines future possibilities and challenges.
机译:尿失禁(UI)是医疗保健的主要问题,全世界4亿人患有不自主的尿液。随着年龄衰老人口的增加,在未来几十年中,UI可能会变得更加突出,经济负担很大。在UI的不同亚型中,压力尿失禁(SUI)是本次审查中最普遍的和焦点。 SUI的主要产后原因是怀孕和分娩,直接创伤到骨盆或影响骨盆地板的医疗治疗,如手术或辐照。治疗隋治疗的保守方法是盆腔物理治疗,行为和生活方式的变化,以及Pessaries的使用。目前的手术治疗方案包括吊索,Colposuspensions,膨胀剂和人工尿括约肌。这些治疗具有有效性的局限性,并承担了长期副作用的风险。此外,手术选择不治疗隋的潜在病理生理原因。因此,迫切需要替代治疗,其是有效的,微创的侵袭性,并且仅具有有限的不利影响风险。再生医学是一种新兴领域,专注于使用前体细胞及其组分的人体组织和器官的修复,替代或再生。本文批判性地评估了隋智管理治疗策略的最新进展,并概述了未来的可能性和挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号